(Q44351237)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621451%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

HIV-1 proprotein processing as a target for gene therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621451%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621451%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Zern MA

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621451%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Strayer DS

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621451%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621451%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621451%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621451%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621451%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

467-477

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621451%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301891

1 November 2019

exact match

0 references

cites work

HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Ribozymes as potential anti-HIV-1 therapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Retroviral vector-mediated expression in primary human T cells of an endoplasmic reticulum-retained CD4 chimera inhibits human immunodeficiency virus type-1 replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Maturation of HIV envelope glycoprotein precursors by cellular endoproteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Active human immunodeficiency virus protease is required for viral infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Human plasma proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Gene therapy using SV40-derived vectors: what does the future hold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Processing and routage of HIV glycoproteins by furin to the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

α-1-Anti-trypsin, an inhibitor of renin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

7 January 2021

The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

7 January 2021

Biochemical and genetic definition of the cellular protease required for HIV-1 gp160 processing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

7 January 2021

Titering replication-defective virus for use in gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301891

7 January 2021